期刊文献+

琥珀酸美托洛尔缓释微囊的制备和体外释药 被引量:5

Preparation and in Vitro Release Evaluation of Metoprolol Succinate Sustained-Release Microcapsules
原文传递
导出
摘要 目的探讨琥珀酸美托洛尔缓释微囊的制备工艺。方法以乙基纤维素作为囊材,采用乳化-溶剂扩散法,应用均匀设计优化处方和制备工艺,并研究其体外释药特性。结果在优化条件下制备的琥珀酸美托洛尔缓释微囊,外形圆整光滑,分布均匀,不粘连,平均粒径为80~90μm,包封率达83.16%,18 h体外释放百分率为96.1%。结论优化条件下可制备的缓释微囊外观较好、包封率高,在体外具有良好的缓释效果。 OBJECTIVE To prepare sustained-release microcapsules of metoprolol succinate(MS) and to investigate the influen- cing factors. METHODS The sustained-release microcapsules of metoprolol succinate were prepared with ethyl cellulose (EC) in one step by the emulsion-solvent diffusion method. Uniform design was used to optimize the formulation and preparation technique. Its re- lease behavior in vitro was studied. RESULTS All microcapsules prepared under the optimum condition were spherical and smooth with the mean particle size in the range of 80 -90 μm. The entrapment efficiency was 83.16% and drug release from the MS microcap- sules during 18 h reached 96. 1% in vitro. CONCLUSION The microcapsules have good morphological characteristics, high entrap- ment efficiency and sustained-release effect in vitro.
出处 《中国药学杂志》 CAS CSCD 北大核心 2012年第23期1920-1924,共5页 Chinese Pharmaceutical Journal
关键词 琥珀酸美托洛尔 缓释微囊 乳化-溶剂扩散法 体外释药 metoprolol succinate sustained-release microcapsule emulsion-solvent diffusion method release behavior in vitro
  • 相关文献

参考文献6

二级参考文献33

  • 1张莉,夏运岳.用电子表格Excel计算药物溶出度Weibull分布参数[J].药学进展,2002,26(1):48-50. 被引量:122
  • 2易岂建.β受体阻滞剂治疗慢性心力衰竭的研究进展[J].国外医学(儿科学分册),1994,21(6):297-300. 被引量:2
  • 3李晓芳,洪慧,何琳.阿司匹林胃漂浮微球的制备[J].广东药学院学报,2006,22(1):13-15. 被引量:10
  • 4Morimoto S, Takahashi Y, Watanabe Y, et al. Chemical modification of erythromycin. Synthesis and antibacterial activity of 6 - o - methylerythromycins [J]. Am J Antibiot, 1984, 37:187 - 189. 被引量:1
  • 5Haznedar. S, Dortun. B. Preparation and in vitro evaluation of Eudragit microspheres containing acetazolamide [J]. International Journal of Pharmaceutics, 2004, 269:131 - 140. 被引量:1
  • 6Myung - Kwan Chun, Hongkee Sah, Hoo - Kyun Choi. Preparation of mucoad- hesive microspheres containing antimicrobial agents for eradication of H. pyloria. [J]. International Journal of Pharmaceuties, 2005, 297:172 - 179. 被引量:1
  • 7Frishman WH, Hainer JW, Sugg J. M-FACT Study Group. A factorial study of combination hypertension treatment with metoprolol succinate extended release and felodipine extended release results of the Metoprolol Succinate Felodipine Antihypertension Combination Trial[J]. Am J Hypertension,2006,19:388-395. 被引量:1
  • 8Sandberg A, Abrahamssom B, Regardh CG, et al. Pharmacokinetic and biopharmaceutic aspects of once daily treatment with metoprolol CR/Zok;a review article[J]. J Clin Pharmacol, 1990,30 : 2-16. 被引量:1
  • 9ICHIKAWA H ,FUJIOKA K,ADEYEYE MC ,et al. Use of ion-exchange resins to prepare 100 microm-sized microcapsules with pro- longed drug-release by the Wurster process [ J ].Int J Pharm, 2001,216(1 -2) :67 -76. 被引量:1
  • 10TORRES D, GARCIA-ENCINA G,SEIJO B ,et al. Biopharmaceutical evaluation of microencapsulated ion-exchange resins contai- ning diclofenac[ J]. Eur J Pharm Biopharm, 1995,21 ( 1 ) : 127 - 132. 被引量:1

共引文献24

同被引文献64

  • 1成虹,胡伏莲,李江.幽门螺杆菌耐药性对其根除治疗影响的研究[J].中华医学杂志,2006,86(38):2679-2682. 被引量:97
  • 2傅红兴,曹高忠,胡明釵,等.一种渗透泵控释胶囊壳及其制备方法.CP,CN101301281[P].2008-11-12. 被引量:3
  • 3成雄凯,翟光喜.盐酸氨溴索渗透泵控释片的制备及体外释放度考察[J].食品与药品,2007,9(11A):31-35. 被引量:6
  • 4GRAHAM D Y, SHIOTANI A. New concepts of resistance in the treatment of Helicobacter pylori infections [ J ]. Nat Clin Pract Gastr, 2008, 5: 321-331. 被引量:1
  • 5MALFERTHEINER P, MEGRAUD F, O'MORAIN C, et al. Current concepts in the management of Helicobacter pylori infec- tion : The maastricht Щ consensus report [ J ]. Gut, 2007, 56 : 772-781. 被引量:1
  • 6GISBERT J P, GISBERT J L, MARCOS S, et al. Empirical res- cue therapy after ltelicobacter pylori treatment failure : A lO-year single-centre study of 500 patients [ J]. Aliment Pharm Therap, 2008, 27(4) : 346-354. 被引量:1
  • 7HANS K, DAVID C, HANNE O, et al. Oral administration of specific yolk antibodies (IgY) may prevent Pseudomonas aeruginosa infections in patients with eystie fibrosis : A phase I feasibility study [ J ] . Pediatr Pulmonol, 2003, 35 ( 6 ) : 432-440. 被引量:1
  • 8WORLEDGE K L, GODISKA R, BARRETT? T A, et al. Oral administration of avian tumor necrosis factor antibodies effectively treats experimental colitis in rats [ J]. Dig Dis Sei, 2000, 45 (12) : 2298-2305. 被引量:1
  • 9LI X Y, JIN L J, TIM A M, et al. Chitosan-alginate microcap- sules for oral delivery of egg yolk immunoglobulin (IgY) [ J ]. J Agric Food Chem, 2007, 55(8) : 2911-2917. 被引量:1
  • 10SHEN C H. The research of water-soluble drug microencapsula- tion and release characteristic [ D ]. Chongqing: Chongqing Uni- versity, 2003. 被引量:1

引证文献5

二级引证文献18

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部